Jemma Day

Jemma Day is a seasoned professional in the life sciences sector, currently serving as a Senior Business Development Manager at Achilles Therapeutics plc since September 2021, where responsibilities include advancing AI-powered precision T cell therapies in ongoing clinical trials for cancer. Prior to this role, Jemma worked as a Senior Life Sciences Consultant at Wellspring (IP Pragmatics Ltd) from March 2019 to September 2021, focusing on intellectual property and technology management. Jemma's experience also includes an Associate position at Imperial Innovations and a role as a Visiting Research Scientist at the Swiss Tropical and Public Health Institute, where involvement included malaria research. Jemma holds a Doctor of Philosophy (DPhil) in Structural Biology from the University of Oxford and a Bachelor's Degree in Biochemistry from UCL.